KLK3 and posterior cortical atrophy: The new assay showed a sensitivity of 95% and a specificity of 72% in a measurement carried out on a cohort of over 300 serum samples, from patients who underwent biopsy, including 138 PCa and 178 non-PCa patients with a PSA level less than 10.0 ng/mL [16].